Susquehanna International Group
EVMN

Susquehanna International Group’s Evommune Inc EVMN Stock Holding History

Susquehanna International Group’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$538K Buy
+40,500
New +$941K ﹤0.01% 9755

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM

Susquehanna International Group's EVMN Position: Q2 2026 in Review

Susquehanna International Group opened a new position in Evommune Inc (EVMN) in Q2 2026: 13,184 shares worth $175K. The stake represents ﹤0.01% of the portfolio and ranks #12072 among its holdings.

95 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • Susquehanna International Group held 13,184 shares of Evommune Inc worth $175K as of Q2 2026.
  • Evommune Inc was a new Susquehanna International Group position in Q2 2026.
  • Evommune Inc made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #12072 holding.
  • 95 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.